Advertisement

International Ophthalmology

, Volume 39, Issue 11, pp 2629–2636 | Cite as

Aqueous humor IL-8, IL-10, and VEGF levels in Fuchs’ uveitis syndrome and Behçet’s uveitis

  • Mert SimsekEmail author
  • Pinar Cakar Ozdal
  • Filiz Akbiyik
  • Mehmet Citirik
  • Nilufer Berker
  • Yasemin Ozdamar Erol
  • Pelin Yilmazbas
Original Paper
  • 58 Downloads

Abstract

Purpose

This study investigated the levels of interleukin (IL)-8, IL-10, and vascular endothelial growth factor (VEGF) in the aqueous humor (AqH) of patients with Behçet’s uveitis (BU) and Fuchs’ uveitis syndrome (FUS) during an inactive period and compared these levels with those in the AqH of noninflammatory healthy control subjects.

Methods

This prospective and case–control study included 33 patients (16 patients with BU and 17 patients with FUS) and 35 control subjects. IL-8, IL-10, and VEGF levels in the AqH were quantified by performing sandwich enzyme-linked immunosorbent assay. Kruskal–Wallis test was used to compare the cytokine levels in the different groups, and statistical significance was set at p < 0.05.

Results

IL-8 levels were significantly higher in the AqH of patients with BU and FUS than in the AqH of control subjects (p < 0.001 and p < 0.001, respectively). IL-10 levels were significantly lower in the AqH of patients with BU than in the AqH of patients with FUS and of control subjects (p = 0.001 and p < 0.001, respectively). Although VEGF levels were higher in the AqH of patients with FUS than in the AqH of patients with BU and of control subjects, the difference was significant only between patients with FUS and control subjects (p < 0.001).

Conclusions

We observed a significant decrease in IL-10 levels in the AqH of patients with BU and a significant increase in VEGF levels in the AqH of patients with FUS compared to controls. IL-8 and VEGF levels showed no significant difference among uveitis patients.

Keywords

Behçet’s uveitis Fuchs’ uveitis syndrome IL-8 IL-10 VEGF 

Notes

Acknowledgements

The authors have no financial interest in any materials used in the study.

Funding

The authors have indicated that they have no financial relationships with any company/corporation. This work was supported by Ankara Department of Turkish Ophthalmological Association [Grant Number 2015-144].

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest. The authors alone are responsible for the content and writing of this article.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Oppenheim JJ, Ruscetti FW, Faltynek C (1994) Cytokines. In: Stites DP, Terr AI, Parslow TG (eds) Basic and clinical immunology, 8th edn. Norwalk, Connecticut, pp 105–123Google Scholar
  2. 2.
    Brocker C, Thompson D, Matsumoto A, Nebert DW, Vasiliou V (2010) Evolutionary divergence and functions of the human interleukin (IL) gene family. Hum Genom 5:30–55Google Scholar
  3. 3.
    Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E et al (2011) Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol 127:701–721PubMedGoogle Scholar
  4. 4.
    Gu C, Wu L, Li X (2013) IL-17 family: cytokines, receptors and signaling. Cytokine 64:477–485PubMedPubMedCentralGoogle Scholar
  5. 5.
    Ivashkiv LB, Donlin LT (2014) Regulation of type I interferon responses. Nat Rev Immunol 14:36–49PubMedPubMedCentralGoogle Scholar
  6. 6.
    Rizzo LV, Xu H, Chan CC, Wiggert B, Caspi RR (1998) IL-10 has a protective role in experimental autoimmune uveoretinitis. Int Immunol 10:807–814PubMedGoogle Scholar
  7. 7.
    Rosenbaum JT, Angell E (1995) Paradoxical effects of IL-10 in endotoxin-induced uveitis. J Immunol 155:4090–4094PubMedGoogle Scholar
  8. 8.
    Deschenes J, Char DH, Kaleta S (1988) Activated T lymphocytes in uveitis. Br J Ophthalmol 72:83–87PubMedPubMedCentralGoogle Scholar
  9. 9.
    Wang XC, Norose K, Yano A, Ohta K, Segawa K (1995) Two-color flow cytometric analysis of activated T lymphocytes in aqueous humor of patients with endogenous versus exogenous uveitis. Curr Eye Res 14:425–433PubMedGoogle Scholar
  10. 10.
    Murphy PM (1997) Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin Hematol 34:311–318PubMedGoogle Scholar
  11. 11.
    Baggiolini M, Walz A, Kunkel SL (1989) Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045–1049PubMedPubMedCentralGoogle Scholar
  12. 12.
    Ferrick MR, Thurau SR, Oppenheim MH, Herbort CP, Ni M, Zachariae CO et al (1991) Ocular inflammation stimulated by intravitreal interleukin-8 and interleukin-1. Invest Ophthalmol Vis Sci 32:1534–1539PubMedGoogle Scholar
  13. 13.
    Curnow SJ, Falciani F, Durrani OM, Cheung CM, Ross EJ, Wloka K et al (2005) Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. Invest Ophthalmol Vis Sci 46:4251–4259PubMedGoogle Scholar
  14. 14.
    Sakaguchi M, Sugita S, Sagawa K, Itoh K, Mochizuki M (1998) Cytokine production by T cells infiltrating in the eye of uveitis patients. Jpn J Ophthalmol 42:262–268PubMedGoogle Scholar
  15. 15.
    Calder VL, Shaer B, Muhaya M, Mclauchlan M, Pearson RV, Jolly G et al (1999) Increased CD4+ expression and decreased IL-10 in the anterior chamber in idiopathic uveitis. Invest Ophthalmol Vis Sci 40:2019–2024PubMedGoogle Scholar
  16. 16.
    Muhaya M, Calder V, Towler HM, Shaer B, McLauchlan M, Lightman S (1998) Characterization of T cells and cytokines in the aqueous humour (AH) in patients with Fuchs’ heterochromic cyclitis (FHC) and idiopathic anterior uveitis (IAU). Clin Exp Immunol 111:123–128PubMedPubMedCentralGoogle Scholar
  17. 17.
    Ongkosuwito JV, Feron EJ, van Doornik CE, Van der Lelij A, Hoyng CB, La Heij EC et al (1998) Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis. Invest Ophthalmol Vis Sci 39:2659–2665PubMedGoogle Scholar
  18. 18.
    Pepper MS, Ferrara N, Orci L, Montesano R (1991) Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181:902–906PubMedGoogle Scholar
  19. 19.
    Vinores SA, Chan CC, Vinores MA, Matteson DM, Chen YS, Klein DA et al (1998) Increased vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGFbeta) in experimental autoimmune uveoretinitis: upregulation of VEGF without neovascularization. J Neuroimmunol 89:43–50PubMedGoogle Scholar
  20. 20.
    Paroli MP, Teodori C, D’Alessandro M, Mariani P, Iannucci G, Paroli M (2007) Increased vascular endothelial growth factor levels in aqueous humor and serum of patients with quiescent uveitis. Eur J Ophthalmol 17:938–942PubMedGoogle Scholar
  21. 21.
    International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080Google Scholar
  22. 22.
    Kimura SJ, Hogan MJ, Thygeson P (1955) Fuchs’ syndrome of heterochromic cyclitis. AMA Arch Ophthalmol 54:179–186PubMedGoogle Scholar
  23. 23.
    Takase H, Futagami Y, Yoshida T, Kamoi K, Sugita S, Imai Y et al (2006) Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis. Invest Ophthalmol Vis Sci 47:1557–1561PubMedGoogle Scholar
  24. 24.
    Sijssens KM, Rijkers GT, Rothova A, Stilma JS, Schellekens PA, de Boer JH (2007) Cytokines, chemokines and soluble adhesion molecules in aqueous humor of children with uveitis. Exp Eye Res 85:443–449PubMedGoogle Scholar
  25. 25.
    Lacomba MS, Martin CM, Chamond RR, Galera JM, Omar M, Estevez EC (2000) Aqueous and serum interferon gamma, interleukin (IL) 2, IL-4, and IL-10 in patients with uveitis. Arch Ophthalmol 118:768–772PubMedGoogle Scholar
  26. 26.
    van Kooij B, Rothova A, Rijkers GT, de Groot-Mijnes JD (2006) Distinct cytokine and chemokine profiles in the aqueous of patients with uveitis and cystoid macular edema. Am J Ophthalmol 142:192–194PubMedGoogle Scholar
  27. 27.
    El-Asrar AM, Struyf S, Kangave D, Al-Obeidan SS, Opdenakker G, Geboes K et al (2011) Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Clin Immunol 139:177–184PubMedGoogle Scholar
  28. 28.
    Chavis PS, Tabbara KF (1995) Behçet’s disease. Int Ophthalmol Clin 35:43–67PubMedGoogle Scholar
  29. 29.
    Charteris DG, Barton K, McCartney AC, Lightman SL (1992) CD4+ lymphocyte involvement in ocular Behçet’s disease. Autoimmunity 12:201–206PubMedGoogle Scholar
  30. 30.
    Ahn JK, Yu HG, Chung H, Park YG (2006) Intraocular cytokine environment in active Behçet uveitis. Am J Ophthalmol 142:429–434PubMedGoogle Scholar
  31. 31.
    Wallace GR, Kondeatis E, Vaughan RW, Verity DH, Chen Y, Fortune F et al (2007) IL-10 genotype analysis in patients with Behçet’s disease. Hum Immunol 68:122–127PubMedGoogle Scholar
  32. 32.
    Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T et al (2010) Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet’s disease susceptibility loci. Nat Genet 42:703–706PubMedGoogle Scholar
  33. 33.
    Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C et al (2010) Genome-wide association study identifies variants in the MCH class I, IL10, and IL23R-IL12RB2 regions associated with Behçet’s disease. Nat Genet 42:698–702PubMedPubMedCentralGoogle Scholar
  34. 34.
    Hill T, Galatowicz G, Akerele T, Lau CH, Calder V, Lightman S (2005) Intracellular T lymphocyte cytokine profiles in the aqueous humour of patients with uveitis and correlation with clinical phenotype. Clin Exp Immunol 139:132–137PubMedPubMedCentralGoogle Scholar
  35. 35.
    Zeilhofer HU, Schorr W (2000) Role of interleukin-8 in neutrophil signaling. Curr Opin Hematol 7:178–182PubMedGoogle Scholar
  36. 36.
    Valentincic NV, de Groot-Mijnes JD, Kraut A, Korosec P, Hawlina M, Rothova A (2011) Intraocular and serum cytokine profiles in patients with intermediate uveitis. Mol Vis 17:2003–2010PubMedPubMedCentralGoogle Scholar
  37. 37.
    Bae JH, Lee SC (2012) Effect of intravitreal methotrexate and aqueous humor cytokine levels in refractory retinal vasculitis in Behcet disease. Retina 32:1395–1402PubMedGoogle Scholar
  38. 38.
    El-Asrar AM, Struyf S, Descamps FJ, Al-Obeidan SA, Proost P, Van Damme J et al (2004) Chemokines and gelatinases in the aqueous humor of patients with active uveitis. Am J Ophthalmol 138:401–411PubMedGoogle Scholar
  39. 39.
    El-Asrar AM, Al-Obeidan SS, Kangave D, Geboes K, Opdenakker G, Van Damme J et al (2011) CXC chemokine expression profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Immunobiology 216:1004–1009PubMedGoogle Scholar
  40. 40.
    Bates DO, Hillman NJ, Williams B, Neal CR, Pocock TM (2002) Regulation of microvascular permeability by vascular endothelial growth factors. J Anat 200:581–597PubMedPubMedCentralGoogle Scholar
  41. 41.
    Clavel G, Bessis N, Lemeiter D, Fardellone P, Mejjad O, Ménard JF et al (2007) Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Clin Immunol 124:158–164PubMedGoogle Scholar
  42. 42.
    Erdem F, Gündoğdu M, Kiki I, Ali Sari R, Kiziltunc A (2005) Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet’s disease. Rheumatol Int 25:599–603PubMedGoogle Scholar
  43. 43.
    Fine HF, Baffi J, Reed GF, Csaky KG, Nussenblatt RB (2001) Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema. Am J Ophthalmol 132:794–796PubMedGoogle Scholar
  44. 44.
    Brooks AM, Grant G, Gillies WE (1986) Changes in the iris vasculature and corneal endothelium in chronic cyclitis. Aust N Z J Ophthalmol 14:189–197PubMedGoogle Scholar
  45. 45.
    Verma LV, Arora R (1990) Clinico-pathologic correlates in Fuchs’ heterochromic iridocyclitis: an iris angiographic study. Indian J Ophthalmol 38:159–161PubMedGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Department of Ophthalmology, Ulucanlar Eye Education and Research HospitalUniversity of Health SciencesAltındağ/AnkaraTurkey
  2. 2.Department of Medical Biochemistry, Faculty of MedicineHacettepe UniversityAnkaraTurkey

Personalised recommendations